Gordon William J, Coravos Andrea R, Stern Ariel D
Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
NPJ Digit Med. 2021 Mar 25;4(1):56. doi: 10.1038/s41746-021-00424-5.
From clinical trials to care delivery, advanced, digitally enabled technologies and analytics offer new approaches to how we think about medicine, health, and biology. The Covid-19 pandemic has accelerated this conversation, and forced a roadmap, once measured in years or decades, to unfold over days, weeks, and months. Yet the scaffolding for this roadmap had already emerged prior to the Covid-19 pandemic. In this perspective, we highlight a special collection of papers on “digital medicine,” which emerged from a symposium held in Boston in 2019 and were published in 2020 and 2021. The symposium was hosted by Harvard Business School and the Harvard MIT Center for Regulatory Science, and included a range of speakers and attendees from industry, government, and academics. We describe their ongoing relevance as we contemplate our early 2021 pandemic reality and the near future of digitally empowered health care.
从临床试验到医疗服务，先进的数字技术和分析方法为我们思考医学、健康和生物学提供了新途径。新冠疫情加速了这一讨论，并迫使原本以数年或数十年衡量的路线图在数天、数周和数月内展开。然而，这一路线图的框架在新冠疫情之前就已经出现。在这篇观点文章中，我们重点介绍了一组关于“数字医学”的论文集，这些论文源自2019年在波士顿举行的一次研讨会，并于2020年和2021年发表。该研讨会由哈佛商学院和哈佛-麻省理工监管科学中心主办，参会者包括来自行业、政府和学术界的众多演讲者和与会人员。在我们思考2021年初的疫情现实以及数字赋能医疗保健的近期未来时，我们阐述了这些论文的持续相关性。
